When it comes to osteoporosis, women are often thought of first, resulting in this insidious disease being overlooked in men.

Treatment with romosozumab is linked to improved BMD and a reduced risk for vertebral fractures among postmenopausal women with osteoporosis.

A worrying number of people in Ireland may unknowingly have low bone mass, or osteopenia, putting them at increased risk of ...

Celltrion USA launches 2 denosumab biosimilars, Stoboclo and Osenvelt, enhancing treatment options for osteoporosis and ...

A daily workout routine, a balanced, nutritious diet, a healthy body mass index (BMI), sufficient calcium intake, exposure to ...

Biocon Biologics’ Denosumab biosimilars, Vevzuo and Evfraxy, have received marketing authorisation in the European Union (EU).

Denosumab is a human monoclonal antibody that targets and binds a protein known as RANKL (Receptor Activator of Nuclear Factor Kappa-B Ligand).

Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd., today announced that ...

Bengaluru: Biocon Biologics Ltd, a fully integrated global biosimilars company and subsidiary of Biocon Ltd., has announced ...

Milk is a powerhouse of nutrition. And when we talk about honey, Ayurveda reveres it as both a medicine and a natural preservative, used extensively for internal and external therapeutic applications.